Structures by: Asiri H. H.
Total: 5
3-(Adamantan-1-yl)-4-phenyl-1-[(4-phenylpiperazin-1-yl)methyl]- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C29H35N5S
Acta Crystallographica Section E (2012) 68, 2 o345
a=11.3342(5)Å b=8.4744(3)Å c=13.7868(6)Å
α=90.00° β=103.864(4)° γ=90.00°
Ethyl 4-{[3-(adamantan-1-yl)-4-phenyl-5-sulfanylidene-4,5-dihydro-1<i>H</i>- 1,2,4-triazol-1-yl]methyl}piperazine-1-carboxylate
C26H35N5O2S
Acta Crystallographica Section E (2012) 68, 2 o531
a=12.0469(6)Å b=20.9213(10)Å c=10.3249(5)Å
α=90.00° β=109.851(6)° γ=90.00°
3-(Adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-phenyl- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C30H37N5S
Acta Crystallographica Section E (2012) 68, 2 o344
a=10.1677(6)Å b=11.3287(7)Å c=12.5331(7)Å
α=67.037(6)° β=85.768(5)° γ=83.547(5)°
2-{[5-(Adamantan-1-yl)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl]sulfanyl}- <i>N</i>,<i>N</i>-dimethylethanamine
C17H28N4S
Acta Crystallographica Section E (2012) 68, 5 o1356
a=12.5133(7)Å b=10.3779(5)Å c=14.3044(8)Å
α=90.00° β=106.766(3)° γ=90.00°
5-(Adamantan-1-yl)-3-[(2-methoxyethyl)sulfanyl]-4-phenyl-4<i>H</i>-1,2,4-triazole
C21H27N3OS
Acta Crystallographica Section E (2012) 68, 8 o2326
a=22.5107(5)Å b=9.7642(2)Å c=19.5594(3)Å
α=90.00° β=116.6790(10)° γ=90.00°